2011
DOI: 10.1111/j.1439-0507.2010.01899.x
|View full text |Cite
|
Sign up to set email alerts
|

Experimental systemic virulence of oral Candida dubliniensis isolates in comparison with Candida albicans, Candida tropicalis and Candida krusei

Abstract: There are no previous studies on the comparative virulence of Candida dubliniensis with other non-albicans species. The aim of this study was to compare the virulence and infection kinetics of C. dubliniensis and other species. Candida albicans, C. dubliniensis, Candida tropicalis and Candida krusei (reference strains) were inoculated intravenously in mice. For infection kinetics evaluation, a group of five animals were sacrificed after 6 h, 3, 7, 14 and 21 days. Microbiological evaluations (liver, spleen, kid… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
14
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 23 publications
1
14
0
Order By: Relevance
“…This is consistent with results using the i.v. model of systemic candidiasis, with high mortality observed with C. albicans and C. tropicalis and low mortality with C. glabrata, C. dubliniensis, and C. parapsilosis (43,44). The exception is C. krusei, which causes variable mortality in disseminated i.v.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This is consistent with results using the i.v. model of systemic candidiasis, with high mortality observed with C. albicans and C. tropicalis and low mortality with C. glabrata, C. dubliniensis, and C. parapsilosis (43,44). The exception is C. krusei, which causes variable mortality in disseminated i.v.…”
Section: Discussionmentioning
confidence: 99%
“…The exception is C. krusei, which causes variable mortality in disseminated i.v. models of systemic candidiasis (43,44). Note that all of these species cause mortality clinically, mostly in immunocompromised or neonatal patients, and the incidence of candidemia due to NAC has increased in the past several years (45).…”
Section: Discussionmentioning
confidence: 99%
“…Using immunocompetent mice, the IV challenge model has been used to compare the virulence of different Candida species [97–99, 107, 111114]. C. albicans is clearly the most virulent species [97, 98, 111, 112, 114], followed closely by C. tropicalis [97, 98, 111, 112, 114].…”
Section: Experimental Models Of Candida Infectionmentioning
confidence: 99%
“…C. albicans is clearly the most virulent species [97, 98, 111, 112, 114], followed closely by C. tropicalis [97, 98, 111, 112, 114]. In contrast, C. krusei and C. parapsilosis were unable to kill the infected animals, even at high inoculum levels, and fungi were eventually cleared from the host [98, 111, 114]. …”
Section: Experimental Models Of Candida Infectionmentioning
confidence: 99%
“…albicans is compounded by continuous intake of antibiotic drugs, anticancer agents, oral contraceptives, HIV protease inhibitors and compromised immune system (Koga-Ito et al, 2011). Plant extracts have been shown to have anticandidal activity (Shai et al,2008(Shai et al, , 2009).…”
Section: Introductionmentioning
confidence: 99%